While injectable interest continues to rise, current evidence supports the use of topical and systemic formulationsnot specific injection protocols
Peptide safety during perimenopause Generally safe peptides: CJC-1295 + Ipamorelin (excellent safety record) BPC-157 (very safe long-term) Selank (minimal side effects) Semax (well-tolerated) GHK-Cu (safe topical and injectable) Start conservatively: Lower doses than younger women Hormones already unstable More sensitive during transition Titrate slowly Monitor carefully: Track symptoms meticulously Regular bloodwork Adjust based on response Stop if concerning effects Contraindications and cautions Avoid peptides if: Active cancer (theoretical GH concerns) Uncontrolled hypertension Severe kidney or liver disease Use caution with: Breast cancer history (discuss with oncologist) Diabetes (monitor glucose with GLP-1s) Thyroid issues (monitor thyroid function) Multiple medications (check interactions) Discuss with physician: Any chronic health conditions If on multiple medications Cancer history Cardiovascular issues See our peptide safety and risks , are peptides legal , research vs pharmaceutical peptides , and peptides vs SARMS
Niacinamide: Known for its ability to support the skin's barrier and improve the look of uneven skin tone, niacinamide works beautifully alongside copper peptides
Researchers working with extended time courses should validate stability for their own assay conditions rather than assuming a fixed window
Additionally, using SIRT1 knockout mice and STAT3 knockout mouse models may provide more conclusive insights into GHKs mechanism of action
It also helps regulate homocysteine, an amino acid that, when elevated, is associated with cardiovascular and neurological risks
